CONTACT US   |  (864) 397-5101

MADE in America Act to Fuel Life Sciences Industry Growth, Enhance American Independence

OpEd published courtesy of Gannett/Greenville News

Patients in the U.S. have faced drug shortages for years.  This was illustrated amid the current pandemic, which was exacerbated by shortages of PPE, testing ingredients and drugs required for COVID-19 treatment.  Although America remains the world’s top innovator in life sciences, it dramatically lags countries such as China and India in the manufacture of antibiotics, active pharmaceutical ingredients formulated into tablets, capsules and medicines (API), vitamin C, many medical devices and PPE.

While South Carolina reaps extraordinary benefits from foreign investment by international manufacturers that contribute significantly to our economy and quality of life, returning the manufacturing and sourcing of life sciences products to our country is not only a powerful economic development driver – it’s a path to national and global stability.   Read on for full article here.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.